Osaka, Japan

Yohei Kobayashi

This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohei Kobayashi. Retrieved from https://idiyas.com/inventor/yohei-kobayashi-c9eor8kf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yohei Kobayashi: Innovator in Pharmaceutical Chemistry

Introduction

Yohei Kobayashi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aminoquinazolinone derivatives. With a total of 2 patents to his name, Kobayashi continues to push the boundaries of medicinal chemistry.

Latest Patents

Kobayashi's latest patents include a 2-heteroaryl aminoquinazolinone derivative. This compound is represented by a specific formula and is described as a pharmaceutically acceptable salt. The compound features various substituents, including heteroaryl and alkyl groups, which enhance its potential therapeutic applications.

Career Highlights

Throughout his career, Yohei Kobayashi has been associated with Sumitomo Pharma Co., Ltd., where he has played a crucial role in advancing pharmaceutical research. His work has been instrumental in developing new compounds that may lead to effective treatments for various medical conditions.

Collaborations

Kobayashi has collaborated with notable colleagues, including Kazuto Mori and Hiroyuki Kitano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

In summary, Yohei Kobayashi is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the development of aminoquinazolinone derivatives, highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…